Ignite Creation Date:
2024-05-05 @ 9:36 AM
Last Modification Date:
2024-10-26 @ 9:04 AM
Study NCT ID:
NCT00004255
Status:
COMPLETED
Last Update Posted:
2013-07-10
First Post:
2000-01-28
Brief Title:
Treatment of Bone Marrow to Prevent Graft-Versus-Host Disease in Patients With Acute or Chronic Leukemia Undergoing Bone Marrow Transplantation
Sponsor:
Chimeric Therapies
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Myelodysplastic Syndromes |
| Graft Versus Host Disease |
| Leukemia |
Keywords:
| Name | View |
|---|---|
| childhood myelodysplastic syndromes | View |
| recurrent childhood acute lymphoblastic leukemia | View |
| recurrent childhood acute myeloid leukemia | View |
| recurrent adult acute myeloid leukemia | View |
| recurrent adult acute lymphoblastic leukemia | View |
| chronic phase chronic myelogenous leukemia | View |
| accelerated phase chronic myelogenous leukemia | View |
| adult acute myeloid leukemia in remission | View |
| adult acute lymphoblastic leukemia in remission | View |
| childhood acute myeloid leukemia in remission | View |
| childhood acute lymphoblastic leukemia in remission | View |
| refractory anemia with excess blasts | View |
| refractory anemia with excess blasts in transformation | View |
| secondary acute myeloid leukemia | View |
| de novo myelodysplastic syndromes | View |
| previously treated myelodysplastic syndromes | View |
| secondary myelodysplastic syndromes | View |
| graft versus host disease | View |